Scholarlink

<p>The most challenging aspects of cancer treatment are multi-drug resistance (MDR) and damage to normal, non-malignant cells. Doxorubicin (Dox)-loaded gold nanoparticles (Dox@AuNPs) were developed and evaluated for enhanced anticancer activity. The nanocomposites exhibited spherical morphology (13 ± 3&#xa0;nm) with a loading efficiency of 52%. In vitro, Dox@AuNPs reduced the IC₅₀ by approximately 50% compared to free Dox in MCF-7 cells. In vivo, treatment significantly suppressed tumor growth and increased median survival (62 days) relative to free Dox (52 days). In addition to conventional efficacy evaluation, Fourier transform infrared (FTIR) spectroscopy was applied to analyze biochemical changes in tumor tissues. Distinct alterations in protein, lipid, and nucleic acid-associated bands were observed, with treated tissues showing partial spectral shifts toward normal profiles. These findings suggest that FTIR may provide additional insight into tissue-level biochemical responses following treatment. While further validation and toxicity assessment are required, the results demonstrate that Dox@AuNPs enhance anticancer efficacy and highlight the potential utility of FTIR as a complementary tool for evaluating therapeutic response.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Doxorubicin-loaded gold nanoparticles for enhanced anticancer efficacy: in vitro, in vivo, and FTIR-based tissue analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月25日

查看全文
  • Amna H. Faid,
  • Ali Abdelaziem,
  • Nehal Ali,
  • Fatma El Zahraa Hussein,
  • Sara Gad,
  • Marwa Sharaky,
  • Heba N. Deif

摘要

The most challenging aspects of cancer treatment are multi-drug resistance (MDR) and damage to normal, non-malignant cells. Doxorubicin (Dox)-loaded gold nanoparticles (Dox@AuNPs) were developed and evaluated for enhanced anticancer activity. The nanocomposites exhibited spherical morphology (13 ± 3 nm) with a loading efficiency of 52%. In vitro, Dox@AuNPs reduced the IC₅₀ by approximately 50% compared to free Dox in MCF-7 cells. In vivo, treatment significantly suppressed tumor growth and increased median survival (62 days) relative to free Dox (52 days). In addition to conventional efficacy evaluation, Fourier transform infrared (FTIR) spectroscopy was applied to analyze biochemical changes in tumor tissues. Distinct alterations in protein, lipid, and nucleic acid-associated bands were observed, with treated tissues showing partial spectral shifts toward normal profiles. These findings suggest that FTIR may provide additional insight into tissue-level biochemical responses following treatment. While further validation and toxicity assessment are required, the results demonstrate that Dox@AuNPs enhance anticancer efficacy and highlight the potential utility of FTIR as a complementary tool for evaluating therapeutic response.